Axial Lumbar Interbody Fusion (AxiaLIF) procedures have gained significant traction in addressing lumbar spinal issues, offering minimally invasive solutions. This technique is especially beneficial for patients suffering from conditions like lumbar spondylolisthesis, degenerative disc disease, and spinal stenosis. As spinal surgery continues to evolve, understanding the biomechanical and clinical evidence supporting AxiaLIF is critical for optimizing patient outcomes.
The AxiaLIF Procedure:
- Description: AxiaLIF is performed using a presacral approach, enabling access to L5-S1 interspaces for discectomy and fusion. This procedural innovation minimizes nerve damage risks commonly associated with traditional techniques.
- Benefits: The procedure allows for anterior stabilization of the lower spine, reducing complications such as bowel injuries which have seen a decline with improved surgical technologies.
Biomechanical and Clinical Evidence:
- Biomechanical Insights:
- AxiaLIF procedures favor minimal disruption to anatomical structures, which is a significant advantage over traditional approaches that might cause excessive strain on spinal elements .
- Variability in neuroforaminal height post-procedure indicates effective disc height restoration and reduced nerve compression .
- Clinical Outcomes and Indications:
- The clinical success of AxiaLIF is evident in improved back pain management and enhanced patient mobility. For instance, studies recorded a significant reduction in patients’ back pain scores after following the procedure for two years .
- Indications for AxiaLIF include degenerative lumbar diseases where traditional surgical approaches pose higher risks .
Safety and Complication Management
The AxiaLIF procedure, while generally safe, requires meticulous preoperative assessments, especially concerning patient selection and anatomical viability for the presacral approach. Surgeons should consider contraindications such as severe lumbar deformities or inadequate bone quality, which may impact surgical results.
AxiaLIF stands out as a cutting-edge solution in spinal surgery by leveraging minimally invasive techniques that promise reduced recovery time and enhanced patient outcomes. Its evolution continues as both biomechanical and clinical evidence highlight its efficacy and safety. Surgeons and healthcare providers must remain informed on advancements within AxiaLIF methodologies to maximize its benefits for lumbar spine conditions.
References
Tobler WD, Gerszten PC, Bradley WD, Raley TJ, Nasca RJ, Block JE.
Minimally invasive axial presacral L5-S1 interbody fusion: two-year clinical and radiographic outcomes. Spine (Phila Pa 1976). 2011;36(20):E1296-1301
Gundanna MI, Miller LE, Block JE. Complications with axial presacral lumbar interbody fusion: A 5-year postmarketing surveillance experience. SAS J. 2011;5(3):90-94
Rapp SM, Miller LE, Block JE. AxiaLIF system: Minimally invasive device for presacral lumbar interbody spinal fusion. Med Devices (Auckl). 2011;4:125-131
Aryan HE, Newman CB, Gold JJ, Acosta FL Jr, Coover C, Ames CP.
Percutaneous axial lumbar interbody fusion (AxiaLIF) of the L5-S1 segment: initial clinical and radiographic experience. Minim Invasive Neurosurg. 2008;51(4):225-230
Zeilstra DJ, Miller LE, Block JE. Axial lumbar interbody fusion: a 6-year single-center experience. Clin Interv Aging. 2013;8:1063-1069
Whang PG, Sasso RC, Patel VV, Ali RM, Fischgrund JS.
Comparison of axial and anterior interbody fusions of the L5-S1 segment: A retrospective cohort analysis. J Spinal Disord Tech. 2013;26(8):437-443
NICE Interventional Procedures Guidance [IPG620]. July 2018.
Abe K et al. Perioperative Complications in 155 Patients Who Underwent Oblique Lateral Interbody Fusion Surgery. Spine. 2016; 42(1): 55-62.
Siasos I, Vakharia K, Khan A, Meyers J, Yavorek S, Pollina J, Dimopoulos V.
Bowel injury in lumbar spine surgery: a review of the literature. J Spine Surg. 2018, March; 4(1): 130-137